About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BPGbio's Lipidomics Expertise Powers Groundbreaking Discovery of Lipid-Rich Cartilage Published in Science

By: via Business Wire
  • Lipid-Rich Cartilage Tissue has the Potential to Revolutionize Reconstructive Surgery and Regenerative Medicine
  • BPGbio’s Advanced Lipid Analysis Critical to Redefining the Role of Skeletal Tissues

 

BPGbio, a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, is thrilled to announce its contribution to a groundbreaking study published in the January 10 issue of Science. This study describes the discovery of a novel lipid-rich tissue type, lipocartilage, which exhibits unique skeletal support properties distinct from classical cartilage rich in extracellular matrix proteins. This discovery has transformative implications for regenerative medicine and reconstructive surgery, offering new pathways for personalized cartilage tissue repair and replacement.

The research team comprehensively characterized lipochondrocytes, lipid vacuole-containing cells that constitute lipocartilage, revealing their evolutionary origins, distinct molecular makeup, and biomechanical properties. These findings redefine how lipid-filled cells contribute to skeletal tissue formation, echoing the elastic support properties of ancient vacuole-containing notochord tissue, while introducing novel applications for modern medicine.

“BPGbio’s world-class multiomics capabilities uniquely positioned us to contribute to this transformative research,” said Niven R. Narain, Ph.D., President and CEO of BPGbio. “As the only commercial company that participated in this groundbreaking study, we are proud to see how our NAi platform and multiomics expertise are driving scientific innovation and advancing regenerative medicine.”

BPGbio’s Lipidomics Expertise

BPGbio’s team spearheaded the technically challenging lipidomics analysis critical to this discovery. The extremely small size of lipocartilage tissue samples posed significant technical hurdles, but BPGbio’s innovative techniques enabled the robust characterization and quantification of lipids across more than 20 lipid classes and approximately 1,000 molecular species. This detailed molecular profiling revealed how the unique lipid composition of lipochondrocytes distinguishes their structural and functional roles from other major types of lipid vacuole-containing cells in the fat tissues, the adipocytes.

“The lipidomics analysis performed by BPGbio represents a remarkable achievement in scientific innovation,” said Mike Kiebish, Ph.D., co-author of the paper and VP of Platform and Translational Sciences, BPGbio. “Our multiomics expertise, especially in lipidomics and translational science, was critical to uncovering the distinct biological role of lipochondrocytes. By combining lipidomics with advanced molecular profiling, we provided unique insights into the novel tissue type, a testament to our cutting-edge capabilities in advancing science.”

“The lipidomics analysis was critical at the early stage of our research project. By revealing vastly different molecular composition of lipid stores between lipochondrocytes and adipocytes, it clearly pointed at the distinct molecular identity of the former cell type. Indeed, all additional molecular characterization that we performed confirmed lipochondrocytes’ unique position among known cell types,” said Maksim Plikus, Ph.D., leading author on the Science study and professor of developmental and cell biology at the University of California, Irvine.

Impact of the Discovery

This paradigm-shifting discovery holds profound implications:

  • Revolutionizing Tissue Repair: Lipochondrocytes’ unique lipid properties can enable development of bio-manufactured tissues for reconstructive surgeries, addressing congenital defects, trauma injuries, and elective procedures with unprecedented precision.
  • Advancing Personalized Medicine: The ability to label and purify lipochondrocytes, using lipid-based markers, provides an efficient method for creating patient-specific skeletal tissues from stem cells.
  • Expanding Regenerative Medicine: The discovery of stable lipid vacuoles in skeletal tissues offers novel insights into creating soft, springy cartilage replacements critical for facial repair.

About BPGbio

BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be modeled using bespoke Bayesian AI specifically designed for solving large-scale biology challenges. Headquartered in greater Boston, the company is at the forefront of a new era in medicine, combining biology, multi-modal data, and AI to transform the way we understand, diagnose, and treat disease. For more information, visit www.bpgbio.com.

Contacts

More News

View More
Lower Rates Put RV Stocks Back in the Fast Lane
Via MarketBeat
Tickers CWH THO WGO
Alphabet: Time to Take Profits, Buy, or Wait for a Pullback?
Via MarketBeat
Topics Artificial Intelligence
Tickers GOOGL
Hershey vs. Mondelez: Which Stock Wins Chocolate Season?
Via MarketBeat
Topics Economy
Tickers HSY MDLZ PEP
Thor Industries Tracking for New Highs in 2026
Via MarketBeat
Topics Economy
Tickers THO
Cintas Stock Sends a Clear Buy Signal as Momentum Builds
Via MarketBeat
Topics Government
Tickers CTAS
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.